CVS Group plc, a leading provider of integrated veterinary services in the UK, has confirmed that certain employees exercised options under the CVS Group 2020 SAYE Plan, resulting in the issuance of 8,299 ordinary shares of 0.2 pence each. These new shares were issued to satisfy the balance of ordinary shares arising from the SAYE Exercise. Following this, the company's total issued share capital stands at 71,721,269 ordinary shares, each carrying one voting right, with no ordinary shares held in treasury.
The figure of 71,721,269 may be used by shareholders as the denominator for the calculations to determine if they are required to notify their interest or a change to their interest in the company under the FCA's Disclosure Guidance and Transparency Rules.
CVS Group plc operates approximately 500 veterinary practices across the UK, Australia, the Netherlands, and the Republic of Ireland, including specialist referral hospitals, out-of-hours sites, laboratories, crematoria, and an online retail business. The company is focused on providing high-quality clinical services to its clients and their animals, with dedicated clinical teams and support colleagues at the core of its strategy.
For further information, shareholders can contact CVS Group plc or its nominated advisers and brokers.